Skip NavigationSkip to Content
Return Return to Search Results

Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma

  1. Author:
    Berndt, S. I.
    Huang, W. Y.
    Chatterjee, N.
    Yeager, M.
    Welch, R.
    Chanock, S. J.
    Weissfeld, J. L.
    Schoen, R. E.
    Hayes, R. B.

  2. Author Address

    NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA. NCI, Frederick Canc Res & Dev Ctr, SAIC Frederick, Frederick, MD 20877 USA. Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15261 USA. Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA. Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA.;Berndt, SI, NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.;berndts@mail.nih.gov
    1. Year: 2007
    2. Date: Sep
  2. Journal: Carcinogenesis
    1. 28
    2. 9
    3. Pages: 1965-1970
  4. Type of Article: Article
  5. ISSN: 0143-3334
  1. Abstract:

    Transforming growth factor beta 1 (TGFB1) is a multifunctional cytokine that has been implicated in the pathogenesis of colorectal neoplasia. To investigate the association between genetic variants in TGFB1 and the risk of colorectal adenoma, we conducted a case-control study of 754 advanced adenoma cases and 769 controls from the baseline screening exam of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Cases included participants diagnosed with advanced left-sided adenoma (>= 1 cm, high-grade dysplasia or villous characteristics), and controls were subjects without evidence of a left-sided polyp by sigmoidoscopy. DNA was extracted from blood specimens, and five single-nucleotide polymorphisms in TGFB1 of known or suggested functional significance (-800G > A, -509C > T, Leu10Pro, Arg25Pro and Thr263Ile) were genotyped. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (95% CIs) for the association between each polymorphism and adenoma. The high TGFB1 producer genotypes, -509TT and 10Pro/Pro, were associated with an increased risk of colorectal adenoma compared with other genotypes (OR = 1.51, 95% CI: 1.04-2.20 and OR = 1.37, 95% CI: 1.02-1.86, respectively). These increased risks, particularly for -509TT, were greater for persons with multiple adenomas (OR = 1.89, 95% CI: 1.16-3.09, P = 0.01) and individuals with rectal adenoma (OR = 2.95, 95% CI: 1.66-5.26, P = 0.0002). Haplotype analysis revealed similar findings under a recessive model. No associations were observed for polymorphisms at codons 25 and 263. In conclusion, variants that enhance TGFB1 production may be associated with an increased risk of advanced colorectal adenoma.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1093/carcin/bgm155
  3. View record in Web of Science®
  4. WOS: 000250676300016

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel